Post-Marketing Surveillance of Long-Term Observation of Gliadel Wafer-Investigation of Vital Prognosis in Patients With High Grade Glioma

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT02300506

Enrollment

507

Registered

2014-11-25

Start date

2014-01-10

Completion date

2016-07-10

Last updated

2018-11-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Malignant Glioma

Keywords

Malignant Glioma, Glioblastoma multiforme

Brief summary

The objective of this study is to determine the survival status of patients enrolled in study GLI01S (all-case observational study).

Interventions

OTHERNo intervention

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Healthy volunteers

Inclusion criteria

* Malignant Glioma, patients enrolled in study GLI01S.

Exclusion criteria

* Corresponding to contraindication of Gliadel. * Not applicable to indications of Gliadel.

Design outcomes

Primary

Measure	Time frame	Description
Survival rate	Up to 3 years	Survival rate of subjects measured up to 3 year after implantation

Countries

Japan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 13, 2026